http://www.mtrinstitute.com/bio-felix.html

Dr. de la Iglesia is Chief Enterprise Officer. Dr. de la Iglesia retired from Parke-Davis/Pfizer as Vice President, Preclinical Worldwide Safety in 2000 after 34 years serving in several research and development management positions. In 2001, he co-founded Cambridge Biotechnology Corporation, a biotechnology pharmaceutical startup in Cambridge, England. In 2003, Dr. de la Iglesia co-founded QRxPharma Pty Ltd, a biopharmaceutical startup company in Brisbane, Australia and served as Chief Scientific Officer and Vice President of Research and Development. In 2007, he co-founded the Michigan Technology and Research Institute, an expert consultancy in health research sciences with a laboratory for genetic biomarkers. He is the Principal of FIP Consulting LLC and serves as a pharmaceutical research expert providing strategic solutions to expedite drug development. Through Bacchus Global Assets, he manages and provides venture funding in the area of commercial real estate. His businesses ventures reside in Ann Arbor , Michigan and his main residence is in Key Biscayne, Florida.